Preparation and Characterization of Plasmid DNA Encapsulated in Liposomes |
Park, Hyo-Min
(College of Pharmacy, Ewha Womans University)
Chung, Soo-Yeon (College of Pharmacy, Ewha Womans University) Go, Eun-Jung (College of Pharmacy, Ewha Womans University) Lee, Hwa-Jeong (College of Pharmacy, Ewha Womans University) |
1 | E. Galanis, R. Vile and S.J. Russell, Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors, Crit. Rev. Oncol. Hematol.,38, 177-192 (2001) DOI ScienceOn |
2 | A.D. Miller, Retroviral vectors, Curr. Top. Microbial. Immunol., 158, 1-24 (1992) DOI |
3 | T.A. Smith, M.G. Mehaffey, D.B. Kayda, J.M. Saunders, S. Yei, B.C. Trapnell, A . McClelland and M. Kaleko, Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice, Nature Genet., 5, 397-402 (1993) DOI ScienceOn |
4 | Y. Setoguchi, H.A. Jaffe, C.-S. Chu and R.G. Crystal, Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation, Am. J. Resp. Cell Mol. BioI., 10, 369-377 (1994) DOI ScienceOn |
5 | Y. Yang, F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol and J.M. Wilson, Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy, Proc. Natl. Acad. Sci. USA, 91, 4407-4411 (1995) |
6 | N. Shi and W.M. Pardridge, Noninvasive gene targeting to the brain, Proc. Natl. Acad. Sci. USA, 97, 7567-7572 (2000) DOI ScienceOn |
7 | J. Huwyler, W. Dafang and W.M. Pardridge, Brain drug delivery of small molecules using immunoliposomes, Proc. Natl. Acad. Sci. USA, 93, 14164-14169 (1996) DOI ScienceOn |
8 | P-A. Monnard, T. Oberholzer and P.L. Luisi, Entrapment of nucleic acids in liposomes, Biochim. Biophys. Acta, 1329, 39-50 (1997) DOI ScienceOn |
9 | E.G. Sarabolac, O. Ludkovski, R. Skirrow, M. Ossanlou, Y.P. Zhang, C. Giebrecht, J. Thompson, S. Thomas, H. Stark, P.R. Cullis and P. Scherrer, Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity, J. Drug Target., 7, 423-437 (2000) DOI ScienceOn |
10 | Y. Yang, Q. Li, H.C.J. Erte and J.M. Wilson, Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses, J. Virol., 69, 2004-2015 (1995) |
11 | D.H. Hamer and P. Leder, Splicing and the formation of stable RNA, Cell, 18, 1299-1302 (1979) DOI ScienceOn |
12 | R.C. Mulligan, B.H. Howard and P. Berg, Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome, Nature (London), 277, 108-114 (1979) DOI ScienceOn |
13 | S. Li and L. Huang, Nonviral gene therapy: promises and challenges, Gene Ther., 7, 31-34 (2000) DOI ScienceOn |
14 | A.G. Schatzlein, Non-viral vectors in cancer gene therapy: principles and progress, Anti-Cancer Drugs, 12, 275-304 (2001) DOI ScienceOn |
15 | J. Smith, Y. Zhang and R. Niven, Toward development of a non-viral gene therapeutic, Adv. Drug Deliv. Rev., 26, 135-150 (1997) DOI ScienceOn |
16 | E.R. Kandimalla and S. Agrawal, Antisense Therapeutics: is it as simple as complementary base recognition, Mol. Med. Today, 6, 72-81 (2000) DOI ScienceOn |
17 | K.J. Harrington, E. Linardakis and R.G. Vile, Transcriptional control: an essential component of cancer gene therapy strategies, Adv. Drug Deliv. Rev., 44, 167-184 (2000) DOI ScienceOn |
18 | S. Akhtar, M.D. Hughes, A. Khan, M. Bibby, M. Hussain, Q. Nawaz, J. Double and P. Sayyed, The delivery of antisense therapeutics, Adv. Drug Deliv. Rev., 44, 3-21 (2000) DOI ScienceOn |
19 | S. Akhtar and S. Agrawal, In vivo studies with antisense oligonucleotides, Trends Pharmacal. Sci., 18, 12-18 (1997) DOI ScienceOn |
20 | M. Sioud, Application of preformed hammerhead ribozymes in gene therapy of cancer, Int. J. Mol. Med., 3, 381-384 (1999) |
21 | D. Sen and C.R. Geyer, DNA enzymes, Curr. Opin. Chem. BioI., 2, 680-687 (1998) DOI ScienceOn |